Treatment (mg/mouse) | Specific Ab dosea | Percent survival (live/treated) |
---|---|---|
No treatment | 0 | 7 (1/14)b |
WNIG (0.1 mg) | 15 | 94 (15/16)c |
IVIG-IL (0.1 mg) | 1.3 | 44 (7/16) |
WNIG (0.5 mg) | 76 | 100 (16/16) |
IVIG-IL (0.5 mg) | 7 | 87 (14/16) |
WNIG (2.0 mg) | 304 | 100 (8/8) |
IVIG-IL (2.0 mg) | 27 | 88 (7/8) |
IVIG-US (2.0 mg) | 7 | 63 (5/8) |